Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S4 from A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia
  1. Home
  2. Publications
  3. Supplementary Figure S4 from A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

Supplementary Figure S4 from A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

Authors:
  • JCJeffrey Crawford
    Jeffrey Crawford
  • RCRoberto A. Calle
    Roberto A. Calle
  • SCSusie M. Collins
    Susie M. Collins
  • YWYan Weng
    Yan Weng
  • SLShannon L. Lubaczewski
    Shannon L. Lubaczewski
  • CBClare Buckeridge
    Clare Buckeridge
  • EWEllen Q. Wang
    Ellen Q. Wang
  • MHMagdalena A. Harrington
    Magdalena A. Harrington
  • ATAnil Tarachandani
    Anil Tarachandani
  • MRMichelle I. Rossulek
    Michelle I. Rossulek
  • JRJames H. Revkin
    James H. Revkin

Open Access
Publisher website
Google Scholar
  • 1 February 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.25124613
Abstract
Median serum unbound and total ponsegromab and GDF-15 concentration–time profiles (semi-log scale)
Keywords
  • BIOLOGICAL AGENTS & THERAPIES
  • CLINICAL TRIAL RESULTS
  • METABOLISM
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.